Ajay Srinivasan

Nashik, MH 422010, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Attention U-Net-Based Segmentation and Hybrid Classification for Detection of Circulating Tumor-Associated Cells.

Attention U-Net-Based Segmentation and Hybrid Classification for Detection of Circulating Tumor-Associated Cells.

Journal: Cancers

Published: July 17, 2026

Liquid Biopsy for Detection of Pancreaticobiliary Cancers by Functional Enrichment and Immunofluorescent Profiling of Circulating Tumor Cells and Their Clusters.

Liquid Biopsy for Detection of Pancreaticobiliary Cancers by Functional Enrichment and Immunofluorescent Profiling of Circulating Tumor Cells and Their Clusters.

Journal: Cancers

Published: March 08, 2024

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer.

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer.

Journal: Oncotarget

Published: December 01, 2022

Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.

Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.

Journal: Oncotarget

Published: November 07, 2022

Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells.

Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells.

Journal: Cancer medicine

Published: July 09, 2022

Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study.

Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study.

Journal: Frontiers in oncology

Published: June 18, 2022

Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells.

Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells.

Journal: Cancers

Published: May 24, 2022

Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers.

Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers.

Journal: PloS one

Published: January 29, 2022

Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma.

Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma.

Journal: Clinical case reports

Published: August 06, 2021

Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory Cancers.

Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory Cancers.

Journal: Frontiers in molecular medicine

Published: July 29, 2021

Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.

Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.

Journal: Oncotarget

Published: August 13, 2020

Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors.

Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors.

Journal: PloS one

Published: July 29, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026